New Data on GLP-1s, Diabetic Retinopathy, and CGMs-Highlights From the ADA's Scientific Sessions. | JAMA;332(7): 519-521, 2024 08 20. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

New Data on GLP-1s, Diabetic Retinopathy, and CGMs-Highlights From the ADA's Scientific Sessions.

Abbasi, Jennifer.

Affiliation

Abbasi J; Director, Medical News & Perspectives, JAMA.

JAMA ; 332(7): 519-521, 2024 08 20.

Article in En | MEDLINE | ID: mdl-39058476

This Medical News article is an interview with Robert Gabbay, MD, PhD, the American Diabetes Association's chief scientific and medical officer.

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 1 / Diabetes Mellitus, Type 2 / Diabetic Retinopathy / Continuous Glucose Monitoring / Glucagon-Like Peptide-1 Receptor Agonists / Insulin Limits: Humans Language: En Journal: JAMA Year: 2024 Document type: Article Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 1 / Diabetes Mellitus, Type 2 / Diabetic Retinopathy / Continuous Glucose Monitoring / Glucagon-Like Peptide-1 Receptor Agonists / Insulin Limits: Humans Language: En Journal: JAMA Year: 2024 Document type: Article Country of publication: